Immunocore Holdings (IMCR) Shares Outstanding (2019 - 2026)

Immunocore Holdings (IMCR) has reported Shares Outstanding (Entity) for 8 consecutive years, with $50.8 million the latest figure, recorded in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 1.29% year-over-year to $50.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.8 million (up 1.29% YoY) and the FY2025 annual result came in at $50.7 million, up 1.25% from the prior year.
• Shares Outstanding (Entity) was little changed at $50.8 million in Q1 2026 per IMCR's latest filing, from $50.7 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for IMCR reached as high as $61.2 million in Q2 2023 and fell as low as $48.4 million in Q1 2023.
• A 5-year average of $51.9 million and a median of $50.3 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) increased 10.69% — and 2024, when it dropped 18.33%.
• Year by year, Shares Outstanding (Entity) stood at $56.4 million in 2022, then retreated by 11.84% to $49.7 million in 2023, then advanced by 0.68% to $50.1 million in 2024, then increased by 1.25% to $50.7 million in 2025, then advanced by 0.28% to $50.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $50.8 million, $50.7 million, and $50.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.